American International Group, Inc. Corcept Therapeutics Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $4,557 - $5,931	216 Added 0.49%	44,346 $1.12 Million
Q4 2023 Feb 13, 2024	SELL	$24.82 - $32.88 $9,679 - $12,823	-390 Reduced 0.88%	44,130 $1.43 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $19,004 - $29,236	865 Added 1.98%	44,520 $1.21 Million
Q2 2023 Aug 04, 2023	SELL	$21.44 - $25.15 $87,989 - $103,215	-4,104 Reduced 8.59%	43,655 $971,000
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $2,707 - $3,450	141 Added 0.3%	47,759 $1.03 Million
Q4 2022 Feb 10, 2023	BUY	$19.95 - $29.96 $3,531 - $5,302	177 Added 0.37%	47,618 $967,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $11,806 - $13,919	478 Added 1.02%	47,441 $1.22 Million
Q2 2022 Aug 12, 2022	SELL	$17.33 - $25.3 $64,484 - $94,141	-3,721 Reduced 7.34%	46,963 $1.12 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $123,098 - $187,738	-7,447 Reduced 12.81%	50,684 $1.14 Million
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $54,036 - $73,754	-3,160 Reduced 5.16%	58,131 $1.15 Million
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $43,827 - $50,174	-2,227 Reduced 3.51%	61,291 $1.21 Million
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $39,360 - $48,151	-1,971 Reduced 3.01%	63,518 $1.4 Million
Q1 2021 May 07, 2021	SELL	$23.49 - $30.56 $16,771 - $21,819	-714 Reduced 1.08%	65,489 $1.56 Million
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $13,474 - $21,921	-803 Reduced 1.2%	66,203 $1.73 Million
Q3 2020 Nov 04, 2020	SELL	$12.46 - $19.98 $19,624 - $31,468	-1,575 Reduced 2.3%	67,006 $1.17 Million
Q2 2020 Aug 12, 2020	BUY	$11.0 - $18.26 $22,517 - $37,378	2,047 Added 3.08%	68,581 $1.15 Million
Q1 2020 May 04, 2020	SELL	$10.11 - $14.04 $33,110 - $45,981	-3,275 Reduced 4.69%	66,534 $791,000
Q4 2019 Feb 05, 2020	SELL	$12.06 - $16.96 $22,901 - $32,207	-1,899 Reduced 2.65%	69,809 $845,000
Q3 2019 Nov 08, 2019	SELL	$10.41 - $14.66 $17,686 - $24,907	-1,699 Reduced 2.31%	71,708 $1.01 Million
Q2 2019 Aug 13, 2019	SELL	$9.78 - $12.76 $11,599 - $15,133	-1,186 Reduced 1.59%	73,407 $818,000
Q1 2019 May 06, 2019	SELL	$10.03 - $15.71 $20,932 - $32,786	-2,087 Reduced 2.72%	74,593 $876,000
Q4 2018 Feb 13, 2019	SELL	$11.29 - $17.19 $11,188 - $17,035	-991 Reduced 1.28%	76,680 $1.02 Million
Q3 2018 Nov 09, 2018	BUY	$12.27 - $15.65 $32,589 - $41,566	2,656 Added 3.54%	77,671 $1.09 Million
Q2 2018 Aug 08, 2018	BUY	$15.3 - $19.69 $256,244 - $329,768	16,748 Added 28.74%	75,015 $1.18 Million
Q1 2018 May 07, 2018	SELL	$14.59 - $25.5 $213,524 - $373,192	-14,635 Reduced 20.07%	58,267 $958,000
Q4 2017 Feb 09, 2018	BUY	$15.77 - $20.72 $185,959 - $244,330	11,792 Added 19.3%	72,902 $1.32 Million
Q3 2017 Nov 09, 2017	BUY	$12.3 - $19.3 $751,653 - $1.18 Million	61,110	61,110 $1.18 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$952 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$576 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$476 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$375 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$219 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account